AVENUE THERAPEUTICS, INC. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- AVENUE THERAPEUTICS, INC. stock issued during period, value, other for the quarter ending 2019-12-31 was $0.00.
- AVENUE THERAPEUTICS, INC. stock issued during period, value, other for the quarter ending 2019-09-30 was $0.00.
- AVENUE THERAPEUTICS, INC. stock issued during period, value, other for the quarter ending 2019-06-30 was $0.00.
- AVENUE THERAPEUTICS, INC. stock issued during period, value, other for the quarter ending 2019-03-31 was $31.50M.
- AVENUE THERAPEUTICS, INC. stock issued during period, value, other for fiscal 2021 was $4.38M.
- AVENUE THERAPEUTICS, INC. stock issued during period, value, other for fiscal 2019 was $31.50M.
- AVENUE THERAPEUTICS, INC. stock issued during period, value, other for fiscal 2017 was $34.23M.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2021-12-31 | $4.38M 10-K · filed 2023-03-31 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $31.50M 10-K · filed 2021-03-31 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | |
| 2019-03-31 | $31.50M 10-Q · filed 2020-05-11 | |
| 2017-12-31 | $34.23M 10-K · filed 2019-03-12 |